Medical Weight Loss for Salisbury, Maryland Residents
Salisbury, Maryland residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Salisbury through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Salisbury Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Salisbury, Maryland residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Salisbury patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
Salisbury is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout downtown Salisbury and the greater Wicomico County area of the Eastern Shore. There is no distance surcharge for Salisbury patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Like much of Maryland, many people in Salisbury want a physician-supervised weight-loss option without local waitlists or unclear pricing. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Salisbury patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Salisbury
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Salisbury address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Salisbury
How do I get treatment from Salisbury?
As a Salisbury, Maryland patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Salisbury?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Salisbury in cold-pack packaging, no lines and no drive.
How much does it cost for Salisbury patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Salisbury do you serve?
We serve patients from across Salisbury by telehealth, including downtown Salisbury and the greater Wicomico County area of the Eastern Shore.
What does treatment cost for Salisbury patients?
The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Salisbury.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Salisbury, Maryland by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.